Dr. Ian P. Grady, MD

Dr. Grady practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Grady's NPI, 1215951371, was assigned on July 26, 2006. Dr. Grady graduated from University of Colorado Anschutz Medical Campus in 1986. Dr. Grady holds California license G73597.

Dr. Grady's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Grady's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Grady is also affiliated with Shasta Regional Medical Center. Dmand AI also links Dr. Grady to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grady practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Grady's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Grady is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Grady's licenses on file in 3 states: California, Oregon and Ohio.

Dmand AI lists mastectomy among the conditions Dr. Grady treats.

CMS data shows 5,845 Medicare services from Dr. Grady across 21 procedure codes in 2024, for 1,414 Medicare patients. Medicare paid $456,782 for them.

CMS counts 1,414 Medicare patients who saw Dr. Grady in 2024. The largest group is 65 to 74, with 753 patients. 73% of them have high cholesterol, and 62% have high blood pressure. 18% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grady's median patient age at 62, with 97% women.

In 2024, Dr. Grady wrote 415 Medicare Part D claims for 116 patients. 97% of them were for generic drugs. CMS names the drug for 363 of them, across 5 drugs with 11 or more claims each, at $5,672 in total drug cost. In 2023, CMS named 292 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Grady for performance year 2024, reported individually. Dr. Grady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of skin biopsy by Dr. Grady, more than 62% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Grady, published from 2008 to 2025. The most frequent topics are Breast Neoplasms, Mammography and Breast Density. Dr. Grady has published most often in Breast J. Dr. Grady's most frequent co-authors are Peter D. Beitsch, MD, Gia M. Compagnoni, MD and Cynara L. Coomer, MD.

CMS Open Payments shows 67 general payments to Dr. Grady from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. GE Healthcare paid the most, $22,492.

Dmand AI lists 1 award for Dr. Grady.

Dr. Grady graduated from University of Colorado Anschutz Medical Campus in 1986.

Dr. Grady is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.